Chlorquine Syrup

About Chlorquine 80 mg/5 ml Syrup

The syrup Chlorquine contains Chloroquine Phosphate and is made by United Laboratories Ltd. Only a doctor can decide if it is suitable for you and how long you should take it.

There are 24 brands of Chloroquine Phosphate listed in Bangladesh. The lowest listed price is Jasochlor 250 mg Tablet at ৳ 1.21 per unit.

What is Chlorquine 80 mg/5 ml Syrup?

Chlorquine is a syrup from United Laboratories Ltd., with the generic name Chloroquine Phosphate. Chloroquine is an anti-malarial drug. It is used for treating and preventing malaria, and also for amoebic hepatitis, amoebic abscess, discoid and systemic lupus erythematosus, and rheumatoid arthritis. The doctor decides the dose and course.

Uses of Chlorquine

Only a doctor can decide if it is suitable for you and how long you should take it. It is also used to treat amoebic hepatitis and amoebic abscess, and in the management of discoid and systemic lupus erythematosus and rheumatoid arthritis. Chlorquine 80 mg/5 ml syrup is used to treat malaria and to suppress malaria in prevention. The dose and course are set by the doctor.

How to use Chlorquine

If a dose is missed or you are unsure about anything, ask your doctor or pharmacist. Measure the liquid with the cap or spoon that comes with the pack. Chlorquine is taken by mouth. Shake the bottle well before each use. If you miss a dose, ask your doctor or pharmacist what to do. The dose and duration of treatment are decided by your doctor based on your age, weight, and the condition being treated.

Side effects of Chlorquine

Rarely, blood problems have been reported. With prolonged high doses, side effects can be more serious, including skin eruptions, occasional loss of skin colour or hair loss, difficulty in focusing, and blurred vision. With long-term high doses, more serious effects can occur, such as skin rashes, hair loss, difficulty focusing the eyes or blurred vision. Tell your doctor if you notice any side effects. Tell your doctor about any side effect.

Safety and precautions

Before taking Chlorquine syrup, tell your doctor if you have porphyria, liver disease, or cirrhosis, as the medicine may worsen these conditions. Always ask your doctor or pharmacist before starting this medicine, especially if you are pregnant, breastfeeding, or taking other medicines. People who need long-term treatment may need eye checks as advised by the doctor. Keep out of reach of children.

Frequently asked questions

What does Chlorquine treat?

Only a doctor can decide if it is suitable for you and how long you should take it. It is also used to treat amoebic hepatitis and amoebic abscess, and in the management of discoid and systemic lupus erythematosus and rheumatoid arthritis.

How should I take Chlorquine?

If a dose is missed or you are unsure about anything, ask your doctor or pharmacist. Measure the liquid with the cap or spoon that comes with the pack.

What are the side effects of Chlorquine?

Rarely, blood problems have been reported. With prolonged high doses, side effects can be more serious, including skin eruptions, occasional loss of skin colour or hair loss, difficulty in focusing, and blurred vision.

Who should be careful with Chlorquine?

Before taking Chlorquine syrup, tell your doctor if you have porphyria, liver disease, or cirrhosis, as the medicine may worsen these conditions. Always ask your doctor or pharmacist before starting this medicine, especially if you are pregnant, breastfeeding, or taking other medicines.

Indications

Chloroquine Phosphate is indicated in the following cases:
  • Treatment of malaria
  • Prophylaxis and suppression of malaria
  • Treatment of amoebic hepatitis and abscess
  • Treatment of discoid and systemic and systemic lupus erythematosus
  • Treatment of rheumatoid arthritis

Pharmacology

Chloroquine is used for malarial prophylaxis (as a suppressive) and in managing acute attacks of malaria. It is highly active against erythrocytic forms of P. vivax, P. malariae and P. falciparum. It influences Hb digestion by increasing intravesicular pH in malaria parasite cells and interferes with the nucleoprotein synthesis of the patient. It is also effective in extra intestinal amoebiasis. In RA chloroquine and more effectively hydroxychloroquine have a disease-modifying effect.

Dosage & Administration

Treatment of Malaria-

Partially immune adults:

A single dose of 4 tablets. In severe attacks, the dosage schedule for non-immune adults should be adopted.

Partially immune children:

  • Under 1 year: 1-2 single dose (in 5 ml spoonful)
  • 1-3 years: 3-4 single dose (in 5 ml spoonful)
  • 3-6 years: 4-6 single dose (in 5 ml spoonful)
  • 6-9 years: 6-9 single dose (in 5 ml spoonful)
In severe attacks, the dosage schedule for non-immune children should be adopted.

Non-immune adults:

  • P. falciparum infections: 4 tablets initially, 2 tablets after 6 to 8 hours and then 2 tablets per day for 2 days
  • P. vivax group infections: A single dose of four tablets followed by a course of treatment with primaquine phosphate (15 mg base daily for fourteen days)

Non-immune Children:

Under 1 year:
  • 1-2 initial dose (in 5 ml spoonful)
  • 1 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
1-3 years:
  • 3-4 initial dose (in 5 ml spoonful)
  • 1-2 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
3-6 years:
  • 4-6 initial dose (in 5 ml spoonful)
  • 2-3 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
6-9 years :
  • 6-9 initial dose (in 5 ml spoonful)
  • 3-5 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)

Prophylaxis and suppression of Malaria-

Adults: 2 tablets taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.

Children (Syrup): The following doses should be taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.
  • Under 1 year: 1 single dose (in 5 ml spoonful)
  • 1-3 years: 2 single dose (in 5 ml spoonful)
  • 3-6 years: 2-3 single dose (in 5 ml spoonful)
  • 6-9 years: 3-5 single dose (in 5 ml spoonful)
Children (Tablets): For practical purpose, children over 12 years may be treated as adults and for those below this age, the following proportions may be applied.
  • Under 1 year: ⅛ adult dose (¼ tablet)
  • 1-4 years: ¼ adult dose (½ tablet)
  • 4-8 years: ½ adult dose (1 tablet)
  • 8-12 years: ¾ adult dose (1.5 tablet)

Interaction

Concomitant therapy with phenylbutazone predisposes to dermatitis, antagonises effect of neostigmine and pyridostigmine, reduces bioavailability of ampicillin. Cimetidine inhibits metabolism of chloroquine raising plasma levels.

Contraindications

There is no absolute contraindication to the use of chloroquine.

Side Effects

Choroquine is well tolerated at the standard dosage regimens, side effects such as headache and gastrointestinal disturbances which may occur are not of a serious nature. Where prolonged high dose is required side effects can be of greater severity and patients may develop skin eruptions, occasional depigmentation or loss of hair, difficulty in accommodation, blurring of vision. Corneal opacities disappear completely when the drug is stopped. Rarely thrombocytopenia, agranulocytosis and aplastic anemia have been reported.

The most serious toxic hazard of prolonged therapy with doses is the occasional development of irreversible retinal damage. For this reason considerable caution is needed in the use of choroquine for long-term high dosage therapy and such use should only be considered when no other drug is available. Defects in visual accommodation may occur on first taking choloquine and patients should be warned regarding driving or operating machinery.

Pregnancy & Lactation

As with all other drugs, the use of choroquine during pregnancy should be avoided if possible, unless in the case of threatening infections, in the judgment of the physician, when the potential benefit outweighs the risk.

Precautions & Warnings

Caution is necessary when giving choroquine to patients with porphyria who also have hepatic dysfunction or cirrhosis as the drug may precipitate severe constitutional symptoms and an increase in the amount of porphyrins excreted in the urine. This reaction is especially apparent in alcoholics. Patients receiving choloquine continuously at higher dose levels for a period longer than 12 months or at weekly intervals for a period of more than 3 years as prophylactic against malaria (or the consumption exceeds 1.6 g/Kg) should undergo ophthalmic examination at three months interval.

Storage Conditions

Store at room temperature in a dry place, away from light.

Alternative brands of Chloroquine Phosphate

Other brands with the same generic name, cheapest first.

See all 24 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.